
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 935 | 1026 | 1150 | 1704 | 3065 | 4117 |
Fund Return | -6.49% | 2.61% | 15.02% | 19.44% | 25.11% | 15.2% |
Place in category | 35 | 7 | 74 | 43 | 11 | 5 |
% in Category | 45 | 4 | 88 | 55 | 18 | 18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Small Cap Fund Dir Bon | 554.91B | -11.35 | 22.26 | 21.86 | ||
Reliance Small Cap Fund Dir Gr | 554.91B | -11.89 | 21.59 | 22.09 | ||
Reliance Small Cap Fund Dir Div | 554.91B | -11.35 | 22.26 | 21.86 | ||
Reliance Small Cap Fund Bonus | 554.91B | -11.57 | 21.25 | 20.70 | ||
Reliance Small Cap Fund Dividend | 554.91B | -12.20 | 20.43 | 20.93 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Pharma Dir Div Payout | 80.81B | -6.12 | 20.69 | 16.03 | ||
Reliance Pharma Fund - Bonus | 80.81B | -5.71 | 20.06 | 14.25 | ||
Reliance Pharma Fund - Growth | 80.81B | -5.71 | 20.06 | 14.25 | ||
Reliance Pharma Direct Bonus | 80.81B | -5.43 | 21.15 | 15.27 | ||
Reliance Pharma Direct Growth | 80.81B | -5.43 | 21.15 | 15.27 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.43 | 1,689.50 | -3.17% | |
Divi's Labs | INE361B01024 | 9.28 | 5,948.00 | -1.29% | |
Lupin | INE326A01037 | 7.27 | 2,044.00 | +0.32% | |
Cipla | INE059A01026 | 5.71 | 1,507.30 | +1.84% | |
Apollo Hospitals | INE437A01024 | 5.31 | 6,920.00 | +2.95% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review